Nan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nan Chen has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Guozhong Zhou
School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming, China
9 shared publicationsRong Long
Department of Endocrinology, Anning First People’s Hospital Affiliated of Kunming University of Science and Technology
8 shared publicationsWei Shi
Department of Endocrinology, Anning First People’s Hospital Affiliated to Kunming University of Science and Technology
8 shared publicationsYu Zhang
Department of Endocrinology, The Affiliated Anning First People’s Hospital of Kunming University of Science and Technology, Kunming, China
7 shared publicationsDefu Kong
Department of Endocrinology, Anning First People’s Hospital Affiliated to Kunming University of Science and Technology
6 shared publicationsWeili Shi
Department of Endocrinology, Anning First People’s Hospital Affiliated to Kunming University of Science and Technology, Kunming, China
5 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1986666
Case Report: KBG syndrome in an adult presenting with diabetes, gout, and hypogonadism
KBG syndrome (MIM #148050) is an autosomal dominant disorder caused by pathogenic variants in ANKRD11 or 16q24.3 microdeletions, classically recognized in children through macrodontia, short stature, skeletal anomalies, and neurodevelopmental delay. How the syndrome presents to adult internal medicine remains poorly documented. A 31-year-old man was admitted with new-onset diabetes (blood glucose 20.0 mmol/L) and an acute gout flare, superimposed on congenital sensorineural deafness, repaired cryptorchidism, and 10 years of recurrent gout. Examination revealed macrodontia of the upper central incisors, kyphoscoliosis, brachydactyly with fifth-finger clinodactyly, bilateral gynecomastia, and small soft testes. Investigations showed preserved β-cell reserve with delayed insulin and C-peptide peaks, negative islet autoantibodies, repeatedly borderline-low testosterone with inadequately normal gonadotropins, and 24-h urinary uric acid excretion at the lower end of the reference range. Maternally inherited diabetes and deafness was initially suspected because diabetes coexisted with deafness, but the burden of congenital anomalies prompted trio whole-exome sequencing, which identified a de novo heterozygous ANKRD11 frameshift (NM_013275.6: c.1903_1907del, p.Lys635Glnfs*26). He was treated with liraglutide, febuxostat, colchicine, and atorvastatin. Over 33 months of follow-up, glycated hemoglobin remained between 4.5% and 5.3% and thyroid function normalized, yet serum urate stayed markedly elevated at nearly every routine measurement, and one gout flare required readmission. This case illustrates delayed recognition of KBG syndrome during adulthood: the characteristic dental, skeletal, and developmental signs had been present since early childhood, yet the syndrome was named only when an acquired metabolic cluster—diabetes, gout, and hypogonadism—brought him to adult endocrine care. The decade of gout preceding glucose intolerance is, to our knowledge, the first such report in KBG syndrome and remains a single observation; whether it reflects an intrinsic urate-handling defect is a hypothesis that merits further study rather than an established association. Careful attention to dental, skeletal, and developmental clues in atypical diabetes can end a long diagnostic odyssey.
- 29 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1986666
Open AccessCase Report: KBG syndrome in an adult presenting with diabetes, gout, and hypogonadism
KBG syndrome (MIM #148050) is an autosomal dominant disorder caused by pathogenic variants in ANKRD11 or 16q24.3 microdeletions, classically recognized in children through macrodontia, short stature, skeletal anomalies, and neurodevelopmental delay. How the syndrome presents to adult internal medicine remains poorly documented. A 31-year-old man was admitted with new-onset diabetes (blood glucose 20.0 mmol/L) and an acute gout flare, superimposed on congenital sensorineural deafness, repaired cryptorchidism, and 10 years of recurrent gout. Examination revealed macrodontia of the upper central incisors, kyphoscoliosis, brachydactyly with fifth-finger clinodactyly, bilateral gynecomastia, and small soft testes. Investigations showed preserved β-cell reserve with delayed insulin and C-peptide peaks, negative islet autoantibodies, repeatedly borderline-low testosterone with inadequately normal gonadotropins, and 24-h urinary uric acid excretion at the lower end of the reference range. Maternally inherited diabetes and deafness was initially suspected because diabetes coexisted with deafness, but the burden of congenital anomalies prompted trio whole-exome sequencing, which identified a de novo heterozygous ANKRD11 frameshift (NM_013275.6: c.1903_1907del, p.Lys635Glnfs*26). He was treated with liraglutide, febuxostat, colchicine, and atorvastatin. Over 33 months of follow-up, glycated hemoglobin remained between 4.5% and 5.3% and thyroid function normalized, yet serum urate stayed markedly elevated at nearly every routine measurement, and one gout flare required readmission. This case illustrates delayed recognition of KBG syndrome during adulthood: the characteristic dental, skeletal, and developmental signs had been present since early childhood, yet the syndrome was named only when an acquired metabolic cluster—diabetes, gout, and hypogonadism—brought him to adult endocrine care. The decade of gout preceding glucose intolerance is, to our knowledge, the first such report in KBG syndrome and remains a single observation; whether it reflects an intrinsic urate-handling defect is a hypothesis that merits further study rather than an established association. Careful attention to dental, skeletal, and developmental clues in atypical diabetes can end a long diagnostic odyssey.
- Open Access
- 3 August 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1861198
Bilateral adrenal adenomas presenting with ACTH-independent Cushing’s syndrome and primary aldosteronism: diagnostic insights from multi-steroid adrenal venous sampling
Background: Primary aldosteronism (PA) is the most prevalent cause of secondary hypertension (HTN), and adrenocorticotropic hormone (ACTH)-independent Cushing’s syndrome (CS) represents a distinct form of adrenal-derived secondary HTN. Their coexistence resulting from aldosterone- and cortisol-producing adenomas (A/CPAs) is an extremely rare clinical entity. This is particularly true for the subtype characterized by bilateral adrenocortical adenomas, in which one adenoma predominantly secretes aldosterone (ALD) and the other predominantly secretes cortisol (COR), for which only limited clinical reports have been published to date. Case description: Both female patients were diagnosed with PA and concurrent ACTH-independent CS. Abdominal computed tomography (CT) revealed bilateral adrenal space-occupying lesions. Adrenal venous sampling (AVS) was subsequently performed using 17α-hydroxyprogesterone (17-OHP), androstenedione (ASD), dehydroepiandrosterone (DHEA) as the reference hormone, which demonstrated lateralized dominance of COR and ALD secretion from opposite adrenal glands. Corresponding clinical features confirmed the diagnosis of A/CPAs in both cases. One patient underwent laparoscopic left adrenal CPA resection, while the other underwent laparoscopic right adrenal CPA resection. Following laparoscopic resection of the CPA in both patients, postoperative COR levels declined, consistent with surgical remission. Spironolactone therapy was initiated. Pathological examination confirmed adrenocortical adenoma. Immunohistochemistry (IHC) showed strong positive expression of CYP11B1 (11β-hydroxylase) and weak expression of CYP11B2 (ALD synthase). Their conditions have remained well controlled to date. Conclusions: In patients with bilateral adrenal adenomas and concurrent PA and ACTH-independent COR excess, imaging alone may fail to identify the functional source of hormone excess. Multi-steroid adrenal venous sampling demonstrated opposing ALD and COR dominance from contralateral adrenal glands, guiding targeted resection of the COR-dominant lesion and postoperative medical control of residual ALD excess. These cases support multi-steroid AVS for individualized adrenal-sparing management.
- 3 August 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1861198
Open AccessBilateral adrenal adenomas presenting with ACTH-independent Cushing’s syndrome and primary aldosteronism: diagnostic insights from multi-steroid adrenal venous sampling
Background: Primary aldosteronism (PA) is the most prevalent cause of secondary hypertension (HTN), and adrenocorticotropic hormone (ACTH)-independent Cushing’s syndrome (CS) represents a distinct form of adrenal-derived secondary HTN. Their coexistence resulting from aldosterone- and cortisol-producing adenomas (A/CPAs) is an extremely rare clinical entity. This is particularly true for the subtype characterized by bilateral adrenocortical adenomas, in which one adenoma predominantly secretes aldosterone (ALD) and the other predominantly secretes cortisol (COR), for which only limited clinical reports have been published to date. Case description: Both female patients were diagnosed with PA and concurrent ACTH-independent CS. Abdominal computed tomography (CT) revealed bilateral adrenal space-occupying lesions. Adrenal venous sampling (AVS) was subsequently performed using 17α-hydroxyprogesterone (17-OHP), androstenedione (ASD), dehydroepiandrosterone (DHEA) as the reference hormone, which demonstrated lateralized dominance of COR and ALD secretion from opposite adrenal glands. Corresponding clinical features confirmed the diagnosis of A/CPAs in both cases. One patient underwent laparoscopic left adrenal CPA resection, while the other underwent laparoscopic right adrenal CPA resection. Following laparoscopic resection of the CPA in both patients, postoperative COR levels declined, consistent with surgical remission. Spironolactone therapy was initiated. Pathological examination confirmed adrenocortical adenoma. Immunohistochemistry (IHC) showed strong positive expression of CYP11B1 (11β-hydroxylase) and weak expression of CYP11B2 (ALD synthase). Their conditions have remained well controlled to date. Conclusions: In patients with bilateral adrenal adenomas and concurrent PA and ACTH-independent COR excess, imaging alone may fail to identify the functional source of hormone excess. Multi-steroid adrenal venous sampling demonstrated opposing ALD and COR dominance from contralateral adrenal glands, guiding targeted resection of the COR-dominant lesion and postoperative medical control of residual ALD excess. These cases support multi-steroid AVS for individualized adrenal-sparing management.
- 5 May 2026
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 33 (5) , 557-568
Association Between Naples Prognostic Score and All-Cause Mortality in Individuals with Cardio-Renal-Metabolic Multimorbidity: A Cohort Study
The Naples Prognostic Score (NPS) has demonstrated prognostic value in oncology and certain chronic diseases. Its utility in cardio-renal-metabolic multimorbidity (CRMM) remains unexplored. This study aims to evaluate the association between NPS and all-cause mortality in individuals with CRMM. We analyzed data from the National Health and Nutrition Examination Survey (1999-2018) comprising 3,602 adults with CRMM. The NPS was derived from serum albumin, total cholesterol (TC), neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR). Weighted Cox proportional hazards models and restricted cubic spline (RCS) analysis were used to evaluate associations between NPS and all-cause mortality. Over a median follow-up of 79 months, 1,621 (41.4%) deaths occurred. After comprehensive adjustment for potential confounders, each 1-point increase in NPS was associated with a 24.6% higher risk of all-cause mortality (HR 1.246, 95% CI 1.150-1.350, P < 0.0001). The HRs for all-cause mortality was 1.133 (95 % CI: 0.846-1.518, P = 0.401) in the medium NPS group and 1.721 (95 % CI: 1.248-2.375, P = 0.0009) in the high NPS group, as compared with the low NPS group. RCS analysis indicated a nonlinear relationship between NPS and all-cause mortality among participants with CRMM (Pnonlinear=0.014). Weighted quantile sum regression analysis identified NLR as the primary contributor to mortality risk (weight: 0.612 at 2 years, 0.580 at 5 years), followed by TC. This study identified a positive, nonlinear association between NPS and all-cause mortality in CRMM individuals. The NPS integrates inflammatory, metabolic, and nutritional biomarkers into a practical prognostic tool that may enhance risk stratification and guide personalized management in multimorbidity.
- 5 May 2026
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 33 (5) , 557-568
Association Between Naples Prognostic Score and All-Cause Mortality in Individuals with Cardio-Renal-Metabolic Multimorbidity: A Cohort Study
The Naples Prognostic Score (NPS) has demonstrated prognostic value in oncology and certain chronic diseases. Its utility in cardio-renal-metabolic multimorbidity (CRMM) remains unexplored. This study aims to evaluate the association between NPS and all-cause mortality in individuals with CRMM. We analyzed data from the National Health and Nutrition Examination Survey (1999-2018) comprising 3,602 adults with CRMM. The NPS was derived from serum albumin, total cholesterol (TC), neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR). Weighted Cox proportional hazards models and restricted cubic spline (RCS) analysis were used to evaluate associations between NPS and all-cause mortality. Over a median follow-up of 79 months, 1,621 (41.4%) deaths occurred. After comprehensive adjustment for potential confounders, each 1-point increase in NPS was associated with a 24.6% higher risk of all-cause mortality (HR 1.246, 95% CI 1.150-1.350, P < 0.0001). The HRs for all-cause mortality was 1.133 (95 % CI: 0.846-1.518, P = 0.401) in the medium NPS group and 1.721 (95 % CI: 1.248-2.375, P = 0.0009) in the high NPS group, as compared with the low NPS group. RCS analysis indicated a nonlinear relationship between NPS and all-cause mortality among participants with CRMM (Pnonlinear=0.014). Weighted quantile sum regression analysis identified NLR as the primary contributor to mortality risk (weight: 0.612 at 2 years, 0.580 at 5 years), followed by TC. This study identified a positive, nonlinear association between NPS and all-cause mortality in CRMM individuals. The NPS integrates inflammatory, metabolic, and nutritional biomarkers into a practical prognostic tool that may enhance risk stratification and guide personalized management in multimorbidity.
- Open Access
- 10 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Mechanism of action of Astragalus membranaceus for treating diabetic foot ulcers based on single-cell RNA sequencing data and network pharmacology
Diabetic foot ulcer is a severe complication of diabetes, characterized by impaired wound healing and immune dysregulation. Although Astragalus membranaceus (AM) has been widely used and reported to exert beneficial effects in diabetic complications, its underlying mechanisms of action in DFU remain incompletely understood. This study integrated single-cell RNA sequencing (scRNA-seq) data from a public bioinformatic cohort (GSE245703; 4 non-diabetic foot ulcer (NFU) and 5 diabetic foot ulcer (DFU) samples) with network pharmacology to explore potential molecular mechanisms by which AM may be involved in DFU pathology. scRNA-seq analysis identified ten major cell types within the DFU microenvironment and revealed significant macrophage heterogeneity. Network pharmacology identified 14 active compounds in AM and their predicted targets, some of which overlapped with macrophage-associated differentially expressed genes. Molecular docking suggested strong binding affinities between selected AM compounds and macrophage-associated hub genes. qPCR validation in a clinical cohort (6 NFU and 9 DFU patients) confirmed differential expression of several candidate hub genes overlapping with predicted AM targets. Collectively, these results provide a single-cell–resolved, systems-level framework that links AM components to macrophage-associated molecular processes in DFU, offering a hypothesis-generating basis for future functional and translational studies.
- 10 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessMechanism of action of Astragalus membranaceus for treating diabetic foot ulcers based on single-cell RNA sequencing data and network pharmacology
Diabetic foot ulcer is a severe complication of diabetes, characterized by impaired wound healing and immune dysregulation. Although Astragalus membranaceus (AM) has been widely used and reported to exert beneficial effects in diabetic complications, its underlying mechanisms of action in DFU remain incompletely understood. This study integrated single-cell RNA sequencing (scRNA-seq) data from a public bioinformatic cohort (GSE245703; 4 non-diabetic foot ulcer (NFU) and 5 diabetic foot ulcer (DFU) samples) with network pharmacology to explore potential molecular mechanisms by which AM may be involved in DFU pathology. scRNA-seq analysis identified ten major cell types within the DFU microenvironment and revealed significant macrophage heterogeneity. Network pharmacology identified 14 active compounds in AM and their predicted targets, some of which overlapped with macrophage-associated differentially expressed genes. Molecular docking suggested strong binding affinities between selected AM compounds and macrophage-associated hub genes. qPCR validation in a clinical cohort (6 NFU and 9 DFU patients) confirmed differential expression of several candidate hub genes overlapping with predicted AM targets. Collectively, these results provide a single-cell–resolved, systems-level framework that links AM components to macrophage-associated molecular processes in DFU, offering a hypothesis-generating basis for future functional and translational studies.
- Open Access
- 10 March 2026
- Published by Elsevier in Metabolism Open
- Vol. 30, 100457
Association between triglyceride glucose-body roundness index and incidence diabetes mellitus: a cohort study
- 10 March 2026
- Published by Elsevier in Metabolism Open
- Vol. 30, 100457
Open AccessAssociation between triglyceride glucose-body roundness index and incidence diabetes mellitus: a cohort study
- Open Access
- 22 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Development and validation of a risk nomogram model for predicting superficial fungal infections in patients with type 2 diabetes mellitus : a cross-sectional study
To develop and validate a nomogram for the individualized prediction of superficial fungal infections (SFI) risk in patients with type 2 diabetes mellitus
- 22 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessDevelopment and validation of a risk nomogram model for predicting superficial fungal infections in patients with type 2 diabetes mellitus : a cross-sectional study
To develop and validate a nomogram for the individualized prediction of superficial fungal infections (SFI) risk in patients with type 2 diabetes mellitus
- Open Access
- 9 May 2025
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 76 (3) , 301-312
Association between the cumulative metabolic score for insulin resistance and diabetes mellitus incidence: a prospective nationwide cohort study in China
Introduction: The relationship between changes in metabolic score for insulin resistance (METS-IR) and diabetes mellitus (DM) remains to be elucidated. The present study sought to explore whether changes in METS-IR were associated with incident DM. Material and methods: This study included 4031 individuals aged over 45 years from the China Health and Retirement Longitudinal Study. Utilizing the K-Means clustering method, participants were divided into four groups. Cumulative METS-IR was employed as a quantitative indicator reflecting changes in METS-IR. Multivariable logistic regression models and restricted cubic splines (RCS) were employed to assess the relationship between changes in METS-IR and DM. Results: During the five-year follow-up, 338 (8.4%) incident DM cases were identified. After adjusting for potential confounders, compared to class 1, the incident DM was significantly higher in class 4 [odds ratio (OR): 2.731, 95% confidence interval (CI): 1.411–5.527, p = 0.003]. When cumulative METS-IR (per SD increase) was introduced as a continuous variable into the multivariate regression model, the association remained significant in Model 3 (OR: 1.393, 95% CI: 1.125–1.715, p = 0.003). Additionally, when cumulative METS-IR was categorized into quartiles, compared to the first quartile, the incident DM was significantly higher in the fourth quartile (OR: 2.022, 95% CI: 1.171–3.501, p = 0.011). In addition, cumulative METS-IR exhibited a nonlinear association with DM (poverall = 0.001, pnon linear = 0.038). Conclusions: Substantial changes in METS-IR were independently associated with the risk of DM in middle-aged and elderly Chinese people. Long-term METS-IR monitoring is significant for early identification and prevention of DM, with significant implications for clinical practice. Keywords: metabolic score for insulin resistance diabetes mellitus China Health and Retirement Longitudinal Study cohort study elderly population
- 9 May 2025
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 76 (3) , 301-312
Open AccessAssociation between the cumulative metabolic score for insulin resistance and diabetes mellitus incidence: a prospective nationwide cohort study in China
Introduction: The relationship between changes in metabolic score for insulin resistance (METS-IR) and diabetes mellitus (DM) remains to be elucidated. The present study sought to explore whether changes in METS-IR were associated with incident DM. Material and methods: This study included 4031 individuals aged over 45 years from the China Health and Retirement Longitudinal Study. Utilizing the K-Means clustering method, participants were divided into four groups. Cumulative METS-IR was employed as a quantitative indicator reflecting changes in METS-IR. Multivariable logistic regression models and restricted cubic splines (RCS) were employed to assess the relationship between changes in METS-IR and DM. Results: During the five-year follow-up, 338 (8.4%) incident DM cases were identified. After adjusting for potential confounders, compared to class 1, the incident DM was significantly higher in class 4 [odds ratio (OR): 2.731, 95% confidence interval (CI): 1.411–5.527, p = 0.003]. When cumulative METS-IR (per SD increase) was introduced as a continuous variable into the multivariate regression model, the association remained significant in Model 3 (OR: 1.393, 95% CI: 1.125–1.715, p = 0.003). Additionally, when cumulative METS-IR was categorized into quartiles, compared to the first quartile, the incident DM was significantly higher in the fourth quartile (OR: 2.022, 95% CI: 1.171–3.501, p = 0.011). In addition, cumulative METS-IR exhibited a nonlinear association with DM (poverall = 0.001, pnon linear = 0.038). Conclusions: Substantial changes in METS-IR were independently associated with the risk of DM in middle-aged and elderly Chinese people. Long-term METS-IR monitoring is significant for early identification and prevention of DM, with significant implications for clinical practice. Keywords: metabolic score for insulin resistance diabetes mellitus China Health and Retirement Longitudinal Study cohort study elderly population
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Heterogeneity of Neutrophils and Immunological Function in Neonatal Sepsis: Analysis of Molecular Subtypes Based on Hypoxia–Glycolysis–Lactylation
Objective: Hypoxia–glycolysis–lactylation (HGL) may play a crucial role in neonatal sepsis (NS). This study aims to identify HGL marker genes in NS and explore immune microenvironment among NS subtypes. Materials and Methods: The gene expression dataset GSE69686, comprising 64 NS cases and 85 controls, was selected for analysis. Based on the screened HGL‐related marker genes, diagnostic prediction models were constructed using nine machine learning algorithms, and molecular subtypes of NS were identified through consensus clustering. Subsequently, the heterogeneity of biological functions and immune cell infiltration among the different subtypes was analyzed. Finally, the marker genes and lactylation were validated using the GSE25504 dataset, clinical samples, and mouse neutrophil, respectively. Results: MERTK, HK3, PGK1, and STAT3 were identified and validated as marker genes, and the diagnostic prediction model for NS constructed using the support vector machine (SVM) algorithm exhibited optimal predictive performance. Based on gene expression patterns, two distinct NS subtypes were identified. Functional enrichment analysis highlighted significant immune‐related pathways, while immune infiltration analysis revealed differences in neutrophil proportions between the subtypes. Furthermore, the expression levels of marker genes were positively correlated with neutrophil infiltration. Importantly, the experimental validation results were consistent with the findings from the bioinformatics analysis. Conclusion: This study identified the distinct NS subtypes and their associated marker genes. These findings will contribute to elucidating the disease’s heterogeneity and establishing appropriate personalized therapeutic approaches.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Open AccessHeterogeneity of Neutrophils and Immunological Function in Neonatal Sepsis: Analysis of Molecular Subtypes Based on Hypoxia–Glycolysis–Lactylation
Objective: Hypoxia–glycolysis–lactylation (HGL) may play a crucial role in neonatal sepsis (NS). This study aims to identify HGL marker genes in NS and explore immune microenvironment among NS subtypes. Materials and Methods: The gene expression dataset GSE69686, comprising 64 NS cases and 85 controls, was selected for analysis. Based on the screened HGL‐related marker genes, diagnostic prediction models were constructed using nine machine learning algorithms, and molecular subtypes of NS were identified through consensus clustering. Subsequently, the heterogeneity of biological functions and immune cell infiltration among the different subtypes was analyzed. Finally, the marker genes and lactylation were validated using the GSE25504 dataset, clinical samples, and mouse neutrophil, respectively. Results: MERTK, HK3, PGK1, and STAT3 were identified and validated as marker genes, and the diagnostic prediction model for NS constructed using the support vector machine (SVM) algorithm exhibited optimal predictive performance. Based on gene expression patterns, two distinct NS subtypes were identified. Functional enrichment analysis highlighted significant immune‐related pathways, while immune infiltration analysis revealed differences in neutrophil proportions between the subtypes. Furthermore, the expression levels of marker genes were positively correlated with neutrophil infiltration. Importantly, the experimental validation results were consistent with the findings from the bioinformatics analysis. Conclusion: This study identified the distinct NS subtypes and their associated marker genes. These findings will contribute to elucidating the disease’s heterogeneity and establishing appropriate personalized therapeutic approaches.
- Open Access
- 8 November 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Diabetes mellitus and latent tuberculosis infection: an updated meta-analysis and systematic review
Background: Previous studies have demonstrated an association between diabetes mellitus (DM) and latent tuberculosis infection (LTBI). This study was conducted to update the current understanding of the association between DM and LTBI. By conducting a systematic review and meta-analysis using adjusted odds ratios (aOR) or risk ratios (aRR), we aimed to further explore the association between DM and LTBI and provide essential reference for future research. Methods: We conducted comprehensive searches in Embase, Cochrane Library, and PubMed without imposing any start date or language restrictions, up to July 19, 2022. Our study selection encompassed observational research that compared from LTBI positive rates in both DM and non-DM groups and reported aRR or aOR results. The quality of the included studies was assessed utilizing the Newcastle–Ottawa Scale. Pooled effect estimates were calculated using random-effects models, along with their associated 95% confidence intervals (CI). Results: We included 22 studies involving 68,256 subjects. Three cohort studies were eligible, with a pooled aRR of 1.26 (95% CI: 0.71–2.23). Nineteen cross-sectional studies were eligible, with a pooled aOR of 1.21 (95% CI: 1.14–1.29). The crude RR (cRR) pooled estimate for three cohort studies was 1.62 (95% CI: 1.03–2.57). Among the cross-sectional studies we included, sixteen studies provided crude ORs, and the crude OR (cOR) pooled estimate was 1.64 (95% CI: 1.36–1.97). In the diagnosis of diabetes, the pooled aOR of the HbA1c group was higher than that of self-reported group (pooled aOR: 1.56, 95% CI: 1.24–1.96 vs. 1.17, 95% CI: 1.06–1.28). Conclusion: Our systematic review and meta-analysis suggest a positive association between DM and LTBI. Individuals with DM may have a higher risk of LTBI compared to those without DM. These findings provide important insights for future research and public health interventions in managing LTBI in diabetic populations.
- 8 November 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Open AccessDiabetes mellitus and latent tuberculosis infection: an updated meta-analysis and systematic review
Background: Previous studies have demonstrated an association between diabetes mellitus (DM) and latent tuberculosis infection (LTBI). This study was conducted to update the current understanding of the association between DM and LTBI. By conducting a systematic review and meta-analysis using adjusted odds ratios (aOR) or risk ratios (aRR), we aimed to further explore the association between DM and LTBI and provide essential reference for future research. Methods: We conducted comprehensive searches in Embase, Cochrane Library, and PubMed without imposing any start date or language restrictions, up to July 19, 2022. Our study selection encompassed observational research that compared from LTBI positive rates in both DM and non-DM groups and reported aRR or aOR results. The quality of the included studies was assessed utilizing the Newcastle–Ottawa Scale. Pooled effect estimates were calculated using random-effects models, along with their associated 95% confidence intervals (CI). Results: We included 22 studies involving 68,256 subjects. Three cohort studies were eligible, with a pooled aRR of 1.26 (95% CI: 0.71–2.23). Nineteen cross-sectional studies were eligible, with a pooled aOR of 1.21 (95% CI: 1.14–1.29). The crude RR (cRR) pooled estimate for three cohort studies was 1.62 (95% CI: 1.03–2.57). Among the cross-sectional studies we included, sixteen studies provided crude ORs, and the crude OR (cOR) pooled estimate was 1.64 (95% CI: 1.36–1.97). In the diagnosis of diabetes, the pooled aOR of the HbA1c group was higher than that of self-reported group (pooled aOR: 1.56, 95% CI: 1.24–1.96 vs. 1.17, 95% CI: 1.06–1.28). Conclusion: Our systematic review and meta-analysis suggest a positive association between DM and LTBI. Individuals with DM may have a higher risk of LTBI compared to those without DM. These findings provide important insights for future research and public health interventions in managing LTBI in diabetic populations.
- Open Access
- 7 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-13
A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is a primary malignant tumour of tubular epithelial origin and is most common in the urinary tract. Growing evidence suggests that oxidative stress (OS), generates high levels of reactive oxygen species (ROS) and free radicals, and plays a critical role in cancer in humans. However, the predictive value of OS-related long non-coding RNAs (lncRNAs) in ccRCC remains unclear. We constructed a predictive signature of survival based on OS-related lncRNAs that were obtained from The Cancer Genome Atlas (TCGA–KIRC), to predict the prognosis of patients with ccRCC. The signature comprised seven lncRNAs: SPART-AS1, AL162586.1, LINC00944, LINC01550, HOXB-AS4, LINC02027, and DOCK9-DT. OS-related signature of lncRNAs had diagnostic efficiency higher than that of clinicopathological variables, with an area of 0.794 under the receiver operating characteristic curve. Additionally, the nomogram based on risk scores and clinicopathological variables (age, gender, grade, stage, M-stage, and N-stage) showed strong predictive performance. Patients with high-risk were found to be more sensitive to the therapeutic drugs ABT.888, AICAR, MS.275, sunitinib, AZD.2281, and GDC.0449. Our constructed the predictive signature can independently predict the prognosis of patients with ccRCC; however, the underlying mechanism needs further investigation.
- 7 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-13
Open AccessA novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is a primary malignant tumour of tubular epithelial origin and is most common in the urinary tract. Growing evidence suggests that oxidative stress (OS), generates high levels of reactive oxygen species (ROS) and free radicals, and plays a critical role in cancer in humans. However, the predictive value of OS-related long non-coding RNAs (lncRNAs) in ccRCC remains unclear. We constructed a predictive signature of survival based on OS-related lncRNAs that were obtained from The Cancer Genome Atlas (TCGA–KIRC), to predict the prognosis of patients with ccRCC. The signature comprised seven lncRNAs: SPART-AS1, AL162586.1, LINC00944, LINC01550, HOXB-AS4, LINC02027, and DOCK9-DT. OS-related signature of lncRNAs had diagnostic efficiency higher than that of clinicopathological variables, with an area of 0.794 under the receiver operating characteristic curve. Additionally, the nomogram based on risk scores and clinicopathological variables (age, gender, grade, stage, M-stage, and N-stage) showed strong predictive performance. Patients with high-risk were found to be more sensitive to the therapeutic drugs ABT.888, AICAR, MS.275, sunitinib, AZD.2281, and GDC.0449. Our constructed the predictive signature can independently predict the prognosis of patients with ccRCC; however, the underlying mechanism needs further investigation.